🧬 PIK3CA Cancer Research

PIK3CA is an oncogene that encodes a protein involved in cell growth and survival pathways. Mutations in this gene are among the most frequently detected alterations in breast cancer and several other cancer types, making it a critical focus for cancer researchers and precision medicine development. Understanding PIK3CA mutations helps scientists identify which patients may benefit from targeted therapies and improved diagnostic approaches.

The study of PIK3CA in cancer research has accelerated significantly in recent years as advanced sequencing technologies have revealed the prevalence and diversity of these mutations across patient populations. Researchers are investigating how PIK3CA mutations drive cancer development, how they affect treatment response, and how they can be leveraged for developing new therapeutic strategies. This biomarker holds promise for improving patient stratification and enabling more personalized treatment decisions in oncology.

On this page, you'll find the latest peer-reviewed research articles, clinical insights, and scientific breakthroughs related to PIK3CA mutations and cancer. These resources represent current findings from the global cancer research community and are designed to help patients, caregivers, and healthcare professionals stay informed about this important area of cancer biology and diagnostics.